A safety and proof of concept efficacy Phase 1b/2a trial of 10XB101
Phase of Trial: Phase I/II
Latest Information Update: 06 May 2019
Price : $35 *
At a glance
- Drugs 10XB 101 (Primary)
- Indications Obesity
- Focus Adverse reactions; First in man; Proof of concept; Therapeutic Use
- 06 May 2019 Status changed from planning to recruiting, according to a 10xBio media release.
- 06 May 2019 Results presented in a 10xBio media release.
- 06 May 2019 According to 10xBio media release, the company has completed the phse 1b portion of this study and will initate the phase 2 protion in the third quarter of 2019.